NCT06930976View on ClinicalTrials.gov

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
GlucoseMetabolismIsotope LabelingImmune System and Related Disorders
Interventions
DRUG

13C6-Glucose

Compounded as 5% 13C6-Glucose in sterile water given IV over 2-4 hours as a split bolus and infusion

Trial Locations (1)

37212

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT06930976 - Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells | Biotech Hunter | Biotech Hunter